Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials-Reference-Cited by-同舟云学术

Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials

Published:2021-07 Issue: Volume:Volume 17 Page:2347-2357
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Diekamp Bettina,Borentain Stephane^ORCID,Fu Dong-Jing,Murray Robert,Heerlein Kristin,Zhang Qiaoyi,Schüle Cornelius,Mathews Maju

Publisher

Informa UK Limited

Reference29 articles.

1. Prevalence and correlates of DSM-5 major depressive and related disorders in the community

2. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States

3. Prevalence of suicide attempt in individuals with major depressive disorder: a meta-analysis of observational surveys

4. Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder

5. Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality;Expert Opinion on Pharmacotherapy;2024-03-03

2. Influence of β‐catenin signaling on neurogenesis in neuropsychiatric disorders: Anxiety and depression;Drug Development Research;2024-02

3. Early effects predict trajectories of response to esketamine in treatment-resistant depression;Journal of Affective Disorders;2023-12

4. The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression;Brain Sciences;2023-10-22

5. Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomes;BMC Psychiatry;2023-10-13